• [[ Whitepaper ]] Connecting With Rare Disease Patient Communities: Patient Advocates

    laureng Whitepapers April 19, 2018
  • [[Whitepaper ]] Disruptive Innovation in Rare Disease Markets

    laureng Whitepapers April 19, 2018
  • Choosing the Right Channel Strategy for Specialty Product Success

    Karina Kusova Clinical Development, Market Access, Orphan Drug Congress, Supply Chain & Manufacturing, Uncategorized, Whitepapers May 3, 2017
  • [Whitepaper] Challenging Conventional Patient Recruitment and Care Strategies for Rare Disease Studies

    Karina Kusova Clinical Development, Orphan Drug Congress, Uncategorized, Whitepapers April 10, 2017
  • [[whitepaper]] The New Reality: Maximizing Value in Rare Disease Launches

    Karina Kusova Clinical Development, Featured on App, Orphan Drug Congress, Uncategorized, Whitepapers April 6, 2017
  • What’s New in Rare Cancer Research? (Spoiler Alert: A Lot!)

    Karina Kusova Advocacy, Clinical Development, Market Access, Orphan Drug Congress, Orphan Drugs Live October 10, 2016

Subscribe to Total Orphan Drugs

Strategy and innovation in the orphan drugs and rare diseases industry
Navigation
  • Development
  • Regulation
  • Advocacy
  • Market Access
  • Partnering & Investment
  • Whitepapers
  • Events
    • USA
  • Search
Reports

Reports

View Post

Download presentation: JCR Biotech for a New Tomorrow – Challenges and Goals

In Orphan Drug Congress, Reports by rachelMay 12, 2014Leave a Comment

At the last World Orphan Drug Congress Asia in 2013, the audience were fortunate to hear from Zen-Ichi Mohri of JCR Pharmaceuticals., Co Ltd. He …

View Post

Whitepaper: A new communications model for rare diseases

In Market Access, Reports, Whitepapers by rachelApril 28, 2014Leave a Comment

Rare diseases present distinct communication requirements and opportunities. While fundamental medical communications principles are universal, the specific characteristics of rare diseases demand a new, highly …

Download: How to access the Brazilian orphan drug market

In Partnering & Investment, Reports by Cristina ValdesFebruary 28, 2014Leave a Comment

As market access strategies become an essential milestone to improve the global access to orphan drugs, huge markets like Brazil are poised to support the …

View Post

Whitepaper: Adaptive Clinical Trials

In Clinical Development, Reports, Whitepapers by CameronFebruary 27, 2014Leave a Comment

For orphan drug development, clinical trials can pose an insurmountable barrier to getting a product to market. This is especially true for substances looking to …

View Post

Interview: What investors are looking for in orphan drug biotechs

In Clinical Development, Market Access, Partnering & Investment, Regulation & Government, Reports by André SingerFebruary 5, 2014Leave a Comment

Following the growth of the orphan drug industry and the increasing appetite of investors, we interviewed Patrick Enright, Managing Director of Menlo Park based venture …

View Post

How to generate leads – the top ten tips in generating marketing qualified leads

In Partnering & Investment, Reports by Caroline HornbyFebruary 5, 2014Leave a Comment

The orphan drugs and rare disease community is, by its very nature, niche. As such it can be hard to reach your target audience, and …

View Post

Download ebook: Patient group insights into the orphan drug industry

In Advocacy, Reports by rachelJanuary 20, 2014Leave a Comment

Over the past few months we have been speaking with representatives from various patient groups across Asia trying to gain a better understanding of how …

View Post

Download: Novartis on the power of rare diseases – found in translation

In Clinical Development, Reports by Caroline HornbyNovember 27, 2013Leave a Comment

Novartis kindly provided this article on the topic, ‘The power of rare diseases: found in translation.’ It was originally published in Science. Download a copy …

  • Page 3 of 5
  • ←
  • 1
  • ...
  • 2
  • 3
  • 4
  • ...
  • 5
  • →

Categories

  • Advocacy
  • Clinical Development
  • Featured on App
  • Market Access
  • Orphan Drug Congress
  • Orphan Drugs Live
  • Partnering & Investment
  • Press Release
  • Regulation & Government
  • Reports
  • Supply Chain & Manufacturing
  • Uncategorized
  • Whitepapers
Toggle the Widgetbar
World Orphan Drug Congress USA
  • Home
  • About Us/Advertise